329 related articles for article (PubMed ID: 12396384)
1. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
Arica B; Kaş HS; Orman MN; Hincal AA
J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.
Sehra S; Dhake AS
J Microencapsul; 2005 Aug; 22(5):521-8. PubMed ID: 16361195
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
Haddadi A; Farboud ES; Erfan M; Aboofazeli R
J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
5. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
[TBL] [Abstract][Full Text] [Related]
7. Submicronparticles from biodegradable polymers.
Jobmann M; Rafler G
Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
[TBL] [Abstract][Full Text] [Related]
8. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
10. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
11. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.
Zaghloul AA; Mustafa F; Siddiqui A; Khan M
Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848
[TBL] [Abstract][Full Text] [Related]
12. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
13. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles.
Srinivasan C; Katare YK; Muthukumaran T; Panda AK
J Microencapsul; 2005 Mar; 22(2):127-38. PubMed ID: 16019899
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres.
Cirpanli Y; Unlü N; Caliş S; Hincal AA
J Microencapsul; 2005 Dec; 22(8):877-89. PubMed ID: 16423759
[TBL] [Abstract][Full Text] [Related]
15. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
Shiga K; Muramatsu N; Kondo T
J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro release behaviour of 5-fluorouracil-loaded microspheres based on poly (L-lactide) and its carbonate copolymers.
Zhu KJ; Zhang JX; Wang C; Yasuda H; Ichimaru A; Yamamoto K
J Microencapsul; 2003; 20(6):731-43. PubMed ID: 14594662
[TBL] [Abstract][Full Text] [Related]
17. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
[TBL] [Abstract][Full Text] [Related]
18. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
19. Long-term release of clodronate from biodegradable microspheres.
Perugini P; Genta I; Conti B; Modena T; Pavanetto F
AAPS PharmSciTech; 2001 Jul; 2(3):E10. PubMed ID: 14727869
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
